Universe Pharmaceuticals INC

NasdaqCM:UPC 株式レポート

時価総額:US$2.8m

Universe Pharmaceuticals 過去の業績

過去 基準チェック /06

Universe Pharmaceuticalsの収益は年間平均-66.4%の割合で減少していますが、 Pharmaceuticals業界の収益は年間 増加しています。収益は年間1.2% 15.9%割合で 減少しています。

主要情報

-66.4%

収益成長率

-66.6%

EPS成長率

Pharmaceuticals 業界の成長6.0%
収益成長率-15.9%
株主資本利益率-69.4%
ネット・マージン-69.4%
前回の決算情報31 Mar 2024

最近の業績更新

We Think That There Are Some Issues For Universe Pharmaceuticals (NASDAQ:UPC) Beyond Its Promising Earnings

Aug 10
We Think That There Are Some Issues For Universe Pharmaceuticals (NASDAQ:UPC) Beyond Its Promising Earnings

Recent updates

Universe Pharmaceuticals INC (NASDAQ:UPC) Not Doing Enough For Some Investors As Its Shares Slump 44%

Nov 14
Universe Pharmaceuticals INC (NASDAQ:UPC) Not Doing Enough For Some Investors As Its Shares Slump 44%

Why Investors Shouldn't Be Surprised By Universe Pharmaceuticals INC's (NASDAQ:UPC) 92% Share Price Plunge

Sep 27
Why Investors Shouldn't Be Surprised By Universe Pharmaceuticals INC's (NASDAQ:UPC) 92% Share Price Plunge

Universe Pharmaceuticals INC's (NASDAQ:UPC) 41% Price Boost Is Out Of Tune With Revenues

Jul 22
Universe Pharmaceuticals INC's (NASDAQ:UPC) 41% Price Boost Is Out Of Tune With Revenues

Universe Pharmaceuticals INC's (NASDAQ:UPC) Price Is Right But Growth Is Lacking After Shares Rocket 31%

May 22
Universe Pharmaceuticals INC's (NASDAQ:UPC) Price Is Right But Growth Is Lacking After Shares Rocket 31%

Universe Pharmaceuticals INC's (NASDAQ:UPC) Shares Bounce 27% But Its Business Still Trails The Industry

Apr 07
Universe Pharmaceuticals INC's (NASDAQ:UPC) Shares Bounce 27% But Its Business Still Trails The Industry

Investors Don't See Light At End Of Universe Pharmaceuticals INC's (NASDAQ:UPC) Tunnel And Push Stock Down 27%

Feb 07
Investors Don't See Light At End Of Universe Pharmaceuticals INC's (NASDAQ:UPC) Tunnel And Push Stock Down 27%

There's No Escaping Universe Pharmaceuticals INC's (NASDAQ:UPC) Muted Revenues Despite A 54% Share Price Rise

Dec 18
There's No Escaping Universe Pharmaceuticals INC's (NASDAQ:UPC) Muted Revenues Despite A 54% Share Price Rise

Universe pharmaceuticals receives Nasdaq notification regarding minimum bid price deficiency

Jul 19

Improved Earnings Required Before Universe Pharmaceuticals INC (NASDAQ:UPC) Shares Find Their Feet

Feb 21
Improved Earnings Required Before Universe Pharmaceuticals INC (NASDAQ:UPC) Shares Find Their Feet

We Think That There Are Some Issues For Universe Pharmaceuticals (NASDAQ:UPC) Beyond Its Promising Earnings

Aug 10
We Think That There Are Some Issues For Universe Pharmaceuticals (NASDAQ:UPC) Beyond Its Promising Earnings

収支内訳

Universe Pharmaceuticals の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。


収益と収入の歴史

NasdaqCM:UPC 収益、費用、利益 ( )USD Millions
日付収益収益G+A経費研究開発費
31 Mar 2427-19103
31 Dec 2330-12104
30 Sep 2332-695
30 Jun 2333-9127
31 Mar 2334-111410
31 Dec 2237-10189
30 Sep 2240-9228
30 Jun 2244-1186
31 Mar 22486155
31 Dec 21489115
30 Sep 21481165
30 Jun 21431053
31 Mar 21391040
31 Dec 2035940
30 Sep 2031831
30 Jun 2031831
31 Mar 2031931
31 Dec 1932831
30 Sep 1933831
30 Sep 1829831

質の高い収益: UPCは現在利益が出ていません。

利益率の向上: UPCは現在利益が出ていません。


フリー・キャッシュフローと収益の比較


過去の収益成長分析

収益動向: UPCは利益が出ておらず、過去 5 年間で損失は年間66.4%の割合で増加しています。

成長の加速: UPCの過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。

収益対業界: UPCは利益が出ていないため、過去 1 年間の収益成長をPharmaceuticals業界 ( 54.6% ) と比較することは困難です。


株主資本利益率

高いROE: UPCは現在利益が出ていないため、自己資本利益率 ( -69.36% ) はマイナスです。


総資産利益率


使用総資本利益率


過去の好業績企業の発掘